TrialClinical pharmacology and therapeutics2020

Incidence of Adverse Drug Reactions in COVID-19 Patients in China: An Active Monitoring Study by Hospital Pharmacovigilance System.

Ji Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.